B+ — FMP rating1.
Quick AnswerQ2 consensus: revenue $9.5B1, EPS $1.331. Thierry Pieton guided Cardiac Ablation Solutions to 11.5-12% (previous 6.6%) in the Q4 earnings call2. 8 consecutive quarters of beat1.
Content generated by AI editorial engine. Written by Stock Expert AI's research desk with AI assistance. Figures come from FMP data and the official sources cited in the article.
The median of 10 price targets is $971, stock is $102, -4.7% vs the analyst consensus median.
B+ — FMP rating1.
Quick AnswerQ2 consensus: revenue $9.5B1, EPS $1.331. Thierry Pieton guided Cardiac Ablation Solutions to 11.5-12% (previous 6.6%) in the Q4 earnings call2. 8 consecutive quarters of beat1.
Next report
Watchlist
Fy27 Revenue Guidance
Medtronic guides FY27 organic revenue growth of 6.75% to 7.25%, with approximately 11.5% to 12% in the first quarter.
Thierry Pieton, CFO - Q4 FY26 Earnings Call - June 3, 2026Cas Growth Share Gain
Cardiac Ablation Solutions grew 78% worldwide in Q4 while gaining 8 additional points of U.S. share.
Geoffrey Martha, Chairman and CEO - Q4 FY26 Earnings Call - June 3, 2026Fy27 Eps Guidance
The company guided FY27 EPS of $5.90 to $6.00.
Thierry Pieton, CFO - Q4 FY26 Earnings Call - June 3, 2026M And A Venture Investment
Medtronic closed or announced nearly $2 billion of additional investments in Q4 under its M&A and venture capital strategy.
Thierry Pieton, CFO - Q4 FY26 Earnings Call - June 3, 2026Tariff Impact Fy27
The company expects a total FY27 tariff impact to COGS of approximately $250 million, including $75 million in the first quarter.
Thierry Pieton, CFO - Q4 FY26 Earnings Call - June 3, 2026Symplicity Renal Denervation
Symplicity renal denervation has accelerated since the NCD and is now annualizing at $100 million.
Geoffrey Martha, Chairman and CEO - Q4 FY26 Earnings Call - June 3, 2026Stock Expert AI - Methodology
Historical V1 earnings-model score (archived, Nov 7, 2026) — not the current MoonshotScore. Current MoonshotScore: MDT stock page
multi-pillar methodology. Cash Runway and Price Momentum strong. Operating Leverage weak.
How is it calculated? ->6 investor frameworks. 2 bullish (Ken Griffin, Buffett), 2 bearish (Klarman, Munger), 2 neutral (Ray Dalio, Jim Simons).
How is it calculated? ->Quality business, but price is high.
How is it calculated? ->Past Performance
Q1 FY27 (September 1, 2026) EPS $1.45 vs $1.39 estimate: beat (+4.3%)1.
No RPO/backlog concentration disclosed in Q4 earnings call.
Form 4 Q1 FY27: 6 transactions, net -$6.48M1.
6 transactions · 6 sales / 0 purchases = net negative flow. Not large in absolute terms against a $130.2B market cap.
Not advice - a structural framework for earnings night. Decision discipline is yours.
Market Outlook
You read it in 5 minutes. When the numbers come out on Tuesday evening - you know what you're looking at.
Data arrives at night. The framework is ready now.
Data arrives on Tuesday evening. The framework is ready on this page: Q2 EPS threshold $1.331, Cardiac Ablation Solutions guidance 11.5-12%2, CapEx threshold "below $503.0M". Three anchors, three scenarios.
Comparison Stock Expert AI is free today — no credit card.
Seeking Alpha $299/yr - analyst opinions + earnings coverage TipRanks $360/yr - Smart Score (1-10) + analyst consensus + insider trades Trendspider $400/yr - AI pattern detection + automated TA + multi-timeframe alerts
Prices as of April 2026. Sources: seekingalpha.com/subscriptions - tipranks.com/pricing - trendspider.com/pricing
Stock Expert AI is free today — no credit card. Council 6-lens analysis + MoonshotScore multi-pillar + Insider tracker + Technical levels - all in one platform, for every stock.
Educational tool, not investment advice. Past performance does not guarantee future results.
Calendar
DATA GAP: Events not in the FMP /stable/calendar feed - Investor day, analyst day, product launches, regulatory dates. These require company IR page scraping or manual calendar entry.
This Medtronic plc (MDT) Q2 FY27 earnings preview covers the analyst consensus, key catalysts, and what to watch on the earnings call.
Medtronic plc (MDT): Consensus EPS, revenue guidance, segment growth rates, and the tone of management commentary — the full breakdown with sources is on this page.
Medtronic plc (MDT): Figures are sourced from Financial Modeling Prep (FMP) fundamentals and consensus data plus official earnings-call transcripts; derived metrics are labeled with their source next to each figure.
Medtronic plc (MDT): No. This page is educational research, not investment advice. It summarizes analyst consensus and company data; consult a licensed financial advisor before making any investment decision.